2m 2m 2m 2m 2m 2m 2m
OMNIAB (OABI)
NASDAQ
$5.16+$0.06 (+1.16%)
Price as of Nov 11, 2026 6:35 PM EST- $743.9MMarket Cap
- 216.77%1-Year Change
- BiotechnologyIndustry
OMNIAB (OABI)
$5.16+$0.06 (+1.16%)
OABI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.10 | ||
Change | -$0.20 (-3.77%) | ||
Open | $5.25 | ||
High | $5.35 | ||
Low | $4.86 | ||
Previous Close | $5.30 | ||
Volume | 1,752,677 | ||
30-Day Average Volume | 1,399,711 | ||
1-Week Change | -0.97% | ||
1-Month Change | 6.47% | ||
1-Year Change | 216.77% | ||
3-Year Change | 20.28% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 145.9M | ||
Total Assets | $290.9M | ||
Market Cap | $743.9M | ||
Enterprise Value | $721.0M | ||
Period: QTR TTM FY | |||
Revenue | $100,000.00 | ||
Net Income | -$15.7M | ||
Free Cash Flow | $10.6M | ||
EBIT | -$15.9M | ||
EBITDA | -$12.8M | ||
Net Working Capital | $54.1M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -56 | ||
Enterprise Value/Revenue | 7,210 | ||
P/B | 3 | ||
P/E | -43 | ||
PEG | 0 | ||
Price/Free Cash Flow | 70 | ||
Price/Operating Cash Flow | 70 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue